June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Clinical factors related to low prevalence of Fuchs’ uveitis syndrome in Japan
Author Affiliations & Notes
  • Yu yoneda
    Boei Ika Daigakko, Tokorozawa, Saitama, Japan
  • Yoshihiko Usui
    Tokyo Ika Daigaku Hachioji Iryo Center Ganka, Hachioji, Tokyo, Japan
  • Rie Tanaka
    Tokyo Daigaku Igakubu Fuzoku Byoin, Bunkyo-ku, Tokyo, Japan
  • Kenichi Namba
    Hokkaido Daigaku Daigakuin Igaku Kenkyuin, Sapporo, Hokkaido, Japan
  • Hiroshi Takase
    Tokyo Ika Shika Daigaku Daigakin Ishigaku Sogo Kenkyuka, Bunkyo-ku, Tokyo, Japan
  • Sentaro Kusuhara
    Kobe Daigaku, Kobe, Hyogo, Japan
  • Nobuyo Yawata
    Kyushu Daigaku Igakubu Daigakuin Igakukei Gakufu Daigakuin Igaku Kenkyuin, Fukuoka, Japan
  • Yosuke Harada
    Hiroshima Daigaku Daigakuin Ikei Kagaku Kenkyuka, Hiroshima, Hiroshima, Japan
  • Ryoji Yanai
    Yamaguchi Daigaku Igakubu Daigakuin Igakukei Kenkyuka, Ube, Yamaguchi, Japan
  • Kazuichi Maruyama
    Osaka Daigaku Daigakuin Igakukei Kenkyuka Igakubu, Suita, Osaka, Japan
  • Kei Nakai
    Yodogawa Kirisutokyo Byoin, Osaka, Osaka, Japan
  • Toshikatsu Kaburaki
    Jichi Ika Daigaku Fuzoku Saitama Iryo Center, Saitama, Japan
  • Yujiro Fujino
    Dokuritsu Gyosei Hojin Chiiki Iryo Kino Suishin Kiko Tokyo Shinjuku Medical Center, Shinjuku-ku, Tokyo, Japan
  • Masaki Takeuchi
    Yokohama Shiritsu Daigaku Igakubu Daigakuin Igaku Kenkyuka, Yokohama, Kanagawa, Japan
  • Masaru Takeuchi
    Boei Ika Daigakko, Tokorozawa, Saitama, Japan
  • Footnotes
    Commercial Relationships   Yu yoneda None; Yoshihiko Usui None; Rie Tanaka None; Kenichi Namba None; Hiroshi Takase None; Sentaro Kusuhara None; Nobuyo Yawata None; Yosuke Harada None; Ryoji Yanai None; Kazuichi Maruyama None; Kei Nakai None; Toshikatsu Kaburaki None; Yujiro Fujino None; Masaki Takeuchi None; Masaru Takeuchi None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, OD5. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yu yoneda, Yoshihiko Usui, Rie Tanaka, Kenichi Namba, Hiroshi Takase, Sentaro Kusuhara, Nobuyo Yawata, Yosuke Harada, Ryoji Yanai, Kazuichi Maruyama, Kei Nakai, Toshikatsu Kaburaki, Yujiro Fujino, Masaki Takeuchi, Masaru Takeuchi; Clinical factors related to low prevalence of Fuchs’ uveitis syndrome in Japan. Invest. Ophthalmol. Vis. Sci. 2023;64(8):OD5.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fuchs’ uveitis syndrome (FUS), first described by Ernst Fuchs in 1906, manifests chronic, granulomatous, and typically unilateral mild anterior segment inflammation. FUS is also referred to as Fuchs’ heterochromic iridocyclitis. The exact etiology of FUS is unknown, but many studies suggested an infectious theory associated with an inflammatory process to rubella. The prevalence of FUS in most developed countries ranges from 1 to 11%, while that in Japan is 0.5 to 0.7%, which is apparently lower.
In this study, we investigated the frequencies of ocular findings characteristic of FUS in Japanese patients and the clinical history, and examined factors associated with the lower prevalence.

Methods : We retrospectively reviewed the medical records of 160 patients diagnosed with FUS at 14 uveitis-specialized centers in Japan between April 2010 and March 2021.

Results : Mean age at diagnosis was 48.3 ± 15.0 years, and male to female ratio was 81:79, which was almost equal to other countries. Regarding subjective symptoms at initial presentation, decreased visual acuity was the most common at 41.3%, followed by blurred vision at 38.1%, and floaters at 7.5%. The reason for referral was idiopathic uveitis at 61.9%, followed by cataract at 25.0%, and high IOP including glaucoma at 16.3%. FUS was correctly diagnosed in only 14.4%. The most common ocular finding was anterior ocular inflammation at 91.9%, followed by stellate-shaped keratic precipitates at 88.1%, cataract and pseudophakia at 88.1%, diffuse iris atrophy at 84.4%, heterochromia at 53.1%, and increased IOP high glaucoma at 36.3%. Of 160 patients, 155 (96.9%) had unilateral FUS. As treatments of these ocular findings, cataract surgery was performed in 52.5%, glaucoma surgery in 10.6%, and vitrectomy in 13.8%. On the other hand, mean follow-up period at the primary general ophthalmologists before being referred to our uveitis specialty facilities was 31.6 ± 50.9 months.

Conclusions : The characteristics of Japanese FUS patients were
comparable with those reported in other countries, which may suggest that the prevalence of FUS could be higher than that observed in previous Japanese studies. The low prevalence of FUS in Japan may be a result of being overlooked and misdiagnosed as mild idiopathic uveitis, cataract, and/or glaucoma.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×